Tenet Healthcare (THC) Non-Current Deffered Revenue (2018 - 2022)

Tenet Healthcare has reported Non-Current Deffered Revenue for 4 years, with the latest figure at $13.0 million in Q4 2022.

• Quarterly Non-Current Deffered Revenue fell 13.33% year-over-year to $13.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $13.0 million (down 13.33% YoY) and the FY2022 annual result came in at $13.0 million, down 13.33% from the prior year.
• Non-Current Deffered Revenue declined to $13.0 million in Q4 2022 per THC's latest filing, from $14.0 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $819.0 million in Q4 2020 and troughed at $13.0 million in Q4 2022.
• A 4-year average of $143.8 million and a median of $17.0 million in 2020 frame the typical range for Non-Current Deffered Revenue.
• The sharpest annual moves came in 2020 and 2021: Non-Current Deffered Revenue soared 4450.0% in 2020, then sank 98.17% in 2021.
• Over 4 years, Non-Current Deffered Revenue stood at $18.0 million in 2019, then jumped by 4450.0% to $819.0 million in 2020, then tumbled by 98.17% to $15.0 million in 2021, then declined by 13.33% to $13.0 million in 2022.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $13.0 million, $14.0 million, and $14.0 million for Q4 2022, Q3 2022, and Q2 2022 respectively.